खोज परिणाम - Baloglu, Erkan

परिणाम को परिष्कृत करें
  1. 1
    CBMT-04. INDUCING MITOCHONDRIAL OXIDATIVE STRESS AND TARGETING CELLULAR STRESS RESPONSE BY INHIBITION OF NAMPT, THE RATE LIMITING ENZYME IN THE NAD+ SALVAGE PATHWAY IN GLIOMA

    CBMT-04. INDUCING MITOCHONDRIAL OXIDATIVE STRESS AND TARGETING CELLULAR STRESS RESPONSE BY INHIBITION OF NAMPT, THE RATE LIMITING ENZYME IN THE NAD+ SALVAGE PATHWAY IN GLIOMA द्वारा Sharma, Pratibha, Senepides, William, Baloglu, Erkan, Puduvalli, Vinay

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  2. 2
    Heterozygous mutation of cysteine(528) in XPO1 is sufficient for resistance to selective inhibitors of nuclear export

    Heterozygous mutation of cysteine(528) in XPO1 is sufficient for resistance to selective inhibitors of nuclear export द्वारा Neggers, Jasper Edgar, Vanstreels, Els, Baloglu, Erkan, Shacham, Sharon, Landesman, Yosef, Daelemans, Dirk

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  3. 3
    Nucleo-cytoplasmic transport as a therapeutic target of cancer

    Nucleo-cytoplasmic transport as a therapeutic target of cancer द्वारा Gravina, Giovanni Luca, Senapedis, William, McCauley, Dilara, Baloglu, Erkan, Shacham, Sharon, Festuccia, Claudio

    प्रकाशित 2014
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  4. 4
    Dual and specific inhibition of NAMPT and PAK4 by KPT-9274 decreases kidney cancer growth

    Dual and specific inhibition of NAMPT and PAK4 by KPT-9274 decreases kidney cancer growth द्वारा Aboud, Omran Abu, Chen, Ching-Hsien, Senapedis, William, Baloglu, Erkan, Argueta, Christian, Weiss, Robert H.

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  5. 5
    A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth

    A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth द्वारा Rane, Chetan, Senapedis, William, Baloglu, Erkan, Landesman, Yosef, Crochiere, Marsha, Das-Gupta, Soumyasri, Minden, Audrey

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  6. 6
    XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells

    XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells द्वारा Taylor‐Kashton, Cheryl, Lichtensztejn, Daniel, Baloglu, Erkan, Senapedis, William, Shacham, Sharon, Kauffman, Michael G., Kotb, Rami, Mai, Sabine

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  7. 7
    EXTH-84. TARGETING THE SALVAGE PATHWAY OF NAD+ GENERATION IN GLIOMAS BY KPT-9274, A NOVEL DUAL INHIBITOR OF PAK4 AND NAMPT

    EXTH-84. TARGETING THE SALVAGE PATHWAY OF NAD+ GENERATION IN GLIOMAS BY KPT-9274, A NOVEL DUAL INHIBITOR OF PAK4 AND NAMPT द्वारा Sharma, Pratibha, Kesanakurti, Divya, Wu, Pei-Jung, Xu, Jihong, Sampath, Deepa, Senapedis, William, Baloglu, Erkan, Puduvalli, Vinay K

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  8. 8
    XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose

    XPO1 target occupancy measurements confirm the selinexor recommended phase 2 dose द्वारा Crochiere, Marsha L., Hannus, Stefan, Hansen, Kerrin, Becker, Frank, Baloglu, Erkan, Lee, Margaret, Kauffman, Michael, Shacham, Sharon, Landesman, Yosef

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  9. 9
    A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds

    A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds द्वारा Crochiere, Marsha L., Baloglu, Erkan, Klebanov, Boris, Donovan, Scott, del Alamo, Diego, Lee, Margaret, Kauffman, Michael, Shacham, Sharon, Landesman, Yosef

    प्रकाशित 2015
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  10. 10
    Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation

    Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation द्वारा Mohammad, Ramzi M., Li, Yiwei, Muqbil, Irfana, Aboukameel, Amro, Senapedis, William, Baloglu, Erkan, Landesman, Yosef, Philip, Philip A., Azmi, Asfar S.

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  11. 11
    Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma

    Novel p21-activated kinase 4 (PAK4) allosteric modulators overcome drug resistance and stemness in pancreatic ductal adenocarcinoma द्वारा Aboukameel, Amro, Muqbil, Irfana, Senapedis, William, Baloglu, Erkan, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael, Philip, Philip A., Mohammad, Ramzi M., Azmi, Asfar S.

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  12. 12
    Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death

    Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death द्वारा Argueta, Christian, Kashyap, Trinayan, Klebanov, Boris, Unger, Thaddeus J., Guo, Cathy, Harrington, Susie, Baloglu, Erkan, Lee, Margaret, Senapedis, William, Shacham, Sharon, Landesman, Yosef

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  13. 13
    Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo

    Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo द्वारा Perwitasari, Olivia, Johnson, Scott, Yan, Xiuzhen, Howerth, Elizabeth, Shacham, Sharon, Landesman, Yosef, Baloglu, Erkan, McCauley, Dilara, Tamir, Sharon, Tompkins, S. Mark, Tripp, Ralph A.

    प्रकाशित 2014
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  14. 14
    Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents

    Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents द्वारा Lee, Sangmin, Mohan, Sanjay, Knupp, Jessica, Chamoun, Kamal, de Jonge, Adrienne, Yang, Fan, Baloglu, Erkan, Shah, Jatin, Kauffman, Michael G., Shacham, Sharon, Bhatnagar, Bhavana

    प्रकाशित 2022
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  15. 15
    Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone

    Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone द्वारा Muqbil, Irfana, Aboukameel, Amro, Elloul, Sivan, Carlson, Robert, Senapedis, William, Baloglu, Erkan, Kauffman, Michael, Shacham, Sharon, Bhutani, Divaya, Zonder, Jeffrey, Azmi, Asfar S., Mohammad, Ramzi M.

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  16. 16
    Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration

    Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration द्वारा Azmi, Asfar S., Li, Yiwei, Muqbil, Irfana, Aboukameel, Amro, Senapedis, William, Baloglu, Erkan, Landesman, Yosef, Shacham, Sharon, Kauffman, Michael G., Philip, Philip A., Mohammad, Ramzi M.

    प्रकाशित 2017
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  17. 17
    Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer

    Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer द्वारा Sexton, Rachel, Mahdi, Zaid, Chaudhury, Rahman, Beydoun, Rafic, Aboukameel, Amro, Khan, Husain Y., Baloglu, Erkan, Senapedis, William, Landesman, Yosef, Tesfaye, Anteneh, Kim, Steve, Philip, Philip A., Azmi, Asfar S.

    प्रकाशित 2019
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  18. 18
    Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance

    Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance द्वारा Khan, Husain Yar, Ge, James, Nagasaka, Misako, Aboukameel, Amro, Mpilla, Gabriel, Muqbil, Irfana, Szlaczky, Mark, Chaker, Mahmoud, Baloglu, Erkan, Landesman, Yosef, Mohammad, Ramzi M., Azmi, Asfar S., Sukari, Ammar

    प्रकाशित 2019
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  19. 19
    Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression

    Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression द्वारा Aboukameel, Amro, Muqbil, Irfana, Baloglu, Erkan, Senapedis, William, Landesman, Yosef, Argueta, Christian, Kauffman, Michael, Chang, Hua, Kashyap, Trinayan, Shacham, Sharon, Neggers, Jasper E., Daelemans, Dirk, Heath, Elisabeth I., Azmi, Asfar S.

    प्रकाशित 2018
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:
  20. 20
    PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma

    PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma द्वारा Khan, Husain Yar, Uddin, Md. Hafiz, Balasubramanian, Suresh Kumar, Sulaiman, Noor, Iqbal, Marium, Chaker, Mahmoud, Aboukameel, Amro, Li, Yiwei, Senapedis, William, Baloglu, Erkan, Mohammad, Ramzi M., Zonder, Jeffrey, Azmi, Asfar S.

    प्रकाशित 2021
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    मूलपाठ
    सूची में सहेजें
    में बचाया:

खोज साधन: